Erik Greb joined the staff of Neurology Reviews in January 2012. Since then, he has attended scientific conferences, conducted video interviews, and written about clinical research in multiple sclerosis, epilepsy, Parkinson's disease, Alzheimer's disease, stroke, and other neurologic disorders. In addition to news articles, Erik has written investigative stories about multiple sclerosis, headache, and epilepsy. He previously wrote about pharmaceutical manufacturing, drug formulation and delivery, quality assurance, and regulation for Pharmaceutical Technology.
News
Researchers identify a cause of L-DOPA–induced dyskinesia in Parkinson’s disease
The identification of a protein that contributes to abnormal involuntary movements may enable the development of improved treatments for Parkinson...
News
Economic burden of migraine increases with the number of treatment failures
Total medical visit costs and total prescription costs are highest among patients with three or more treatment failures.
News
Prior head injury is associated with severe Parkinson’s disease phenotype
Head injury before diagnosis was associated with greater motor and nonmotor symptom burden in an analysis of two patient cohorts.
News
Financial incentives affect the adoption of biosimilars
Adoption of infliximab biosimilars proceeded more slowly at an academic medical center than at a neighboring VAMC, where financial incentives to...
News
Financial incentives affect the adoption of biosimilars
Adoption of infliximab biosimilars proceeded more slowly at an academic medical center than at a neighboring VAMC, where financial incentives to...
News
How do neurologists choose an acute treatment for migraine?
STOWE, VT. – The route of administration, the medicine’s tolerability, and the patient’s preferences all must be considered to enable effective...
News
Database will collect data on COVID-19 in patients with MS
A registry is gathering information on patients throughout the United States with a view to understanding outcomes and improving treatment.
News
American Lung Association announces $25 million initiative to end COVID-19
The initiative will fund research, improve public health measures, and promote preparedness for future respiratory virus pandemics.
News
Amid coronavirus concerns, researchers urge mental health interventions for patients with dementia
The response of dementia experts and mental health professionals in China to the COVID-19 pandemic could inform interventions worldwide for...
News
When is preventive treatment of migraine appropriate?
STOWE, VT. – Preventive treatment of migraine can reduce disability and decrease the risk of transformation to...
News
How can neurologists diagnose and treat menstrual migraine?
STOWE, VT. – The disorder is associated with greater disability than nonmenstrual migraine and may be harder to...
News
Nearly 24 tests for the novel coronavirus are available
Laboratories and clinics still face challenges that include shortages of tests, shortages of components such as reagents, and backlogs.
News
Leflunomide-hydroxychloroquine combination for Sjögren’s shows potential
Treatment was associated with decreased disease activity at 24 weeks, compared with placebo.
News
Researchers develop score to predict risk of stroke among migraineurs with aura
LOS ANGELES – Once it has been validated, the score could allow physicians to treat patients’ risk factors and...
News
Teriflunomide increases the likelihood of achieving NEDA in relapsing-remitting MS
WEST PALM BEACH, FLA. – Teriflunomide decreases the risks of relapse, relapse resulting in hospital admission, and...